(Q28268835)

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Prehospital venous access in an urban paramedic system--a prospective on-scene analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Hazards of oral feeding in severe hypoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Reactive hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Response to Glucagon in Small-for-dates Hypoglycaemic and Non-hypoglycaemic Newborn Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Evaluation and outcome of emergency room patients with transient loss of consciousness

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Hypoglycemia: causes, neurological manifestations, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Hyperinsulinism: rare cause of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Severe hypoglycemia in diabetic patients: frequency, causes, prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Relation of counterregulatory responses to hypoglycemia in type I diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Drug-induced hypoglycemia. A review based on 473 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

A review of hypoglycemia and alcoholism with or without liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Meticulous control of diabetes: benefits, risks, and precautions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Diabetes and hypoglycemia in chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Profound spontaneous hypoglycaemia in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Spontaneous Hypoglycemia in End-Stage Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Hypoglycemia: pathogenesis, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Progress review: hypoglycemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Hypoglycemic brain injury. I. Metabolic and light microscopic findings in rat cerebral cortex during profound insulin-induced hypoglycemia and in the recovery period following glucose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Muscle wasting after prolonged hypoglycaemic coma: case report with electrophysiological data

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Cognitive function during hypoglycaemia in type I diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Comparison of blood glucose test strips in the detection of neonatal hypoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Blood Glucose Measurement with Dextrostix and New Reflectance Meter

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Correlation of Dextrostix values with true glucose in the range less than 50 mg/dl

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Glucose Counterregulation in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Impaired Counterregulation of Hypoglycemia in Insulin-dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Glucagon and the A cell: physiology and pathophysiology (first two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Rdevance of Glucose Counterregulatory Systems to Patients with Diabetes: Critical Roles of Glucagon and Epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

The physiological function of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Letter: Glucagon and blood sugar

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Glucagon physiology and pathophysiology in the light of new advances

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Glucagon, Diarrhea, and Cerebral Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Intranasal glucagon raises blood glucose concentrations in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Characterization of the Glucagon Response to Hypoglycemia in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Life-Threatening Reaction to Glucagon in a Patient with Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Blood sugar response to glucagon in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Allergic Response to Glucagon Injection as a Result of Insulin Contamination

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

The metabolic response to glucagon and glucagon-(1-21)-peptide in normal subjects and non insulin dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Glucagon treatment of insulin reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

TREATMENT OF INSULIN HYPOGLYCEMIA IN DIABETIC CAMPERS; A COMPARISON OF GLUCAGON (1 AND 2 MG.) AND GLUCOSE

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021

Serum glucose changes after administration of 50% dextrose solution: pre- and in-hospital calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981658-0

7 January 2021